2-APB decreased the cytokine secretions in human DC. by Romain Félix (586765)

IL-1β decreases RBP4 production. by Primoz Kotnik (382835)

Receptor specific silencing decreases NGF induced apoptosis. by Alessandra Micera (294762)

“…A 37.5%-decrease (*) and a 50%-decrease (**) of apoptotic signal were detected respectively in p75^NTR-siRNA and p75^NTR/trkA^NGFR-siRNA (p<.05).…”

VGB decreased activation of the mTOR pathway in vivo. by Bo Zhang (6559)

FHL2 silencing decreases osteosarcoma cell growth. by Julia Brun (286504)

FLZ decreased the expression of phospho-APP and APP-CTF. by Xiu-Qi Bao (479278)

DataSheet_2_A cyclic peptide-based PROTAC induces intracellular degradation of palmitoyltransferase and potently decreases PD-L1 expression in human cervical cancer cells.docx by Yu-Ying Shi (15975992)

“…Introduction<p>Our previous research has found that degradation of palmitoyltransferase in tumor cells using a linear peptide PROTAC leads to a significant decrease in PD-L1 expression in tumors. …”

DataSheet_1_A cyclic peptide-based PROTAC induces intracellular degradation of palmitoyltransferase and potently decreases PD-L1 expression in human cervical cancer cells.docx by Yu-Ying Shi (15975992)

“…Introduction<p>Our previous research has found that degradation of palmitoyltransferase in tumor cells using a linear peptide PROTAC leads to a significant decrease in PD-L1 expression in tumors. …”

Telomerase inhibition decreases the proliferation and tube formation of HUVECs. by Nadine Mahfouz (4097566)

Time allocation may not decrease with price for a non-linear microscopic utility of leisure. by Ritwik K. Niyogi (427932)

“…We normalised by the trial duration of 25 price, instead of simply normalizing by the price, to emphasise that <i>TA</i> is a macroscopic quantitity and to be consistent with the procedure in the example data <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1003894#pcbi.1003894.s001" target="_blank">Figure S1</a>.…”

CCN3 protein decreases β-cell proliferation. by Renée Paradis (326111)

Effects of siRNA TMPRSS2-ERG III and IV on cell death pathways. by Giorgia Urbinati (554921)

Decreased cell stiffness after dissociation of intercellular adhesion. by Kristina Seiffert-Sinha (627059)

“…At each interval, we obtained (<b>A</b>) microscopic images (original magnification: 100x), (<b>B</b>) AFM topography images (scan size <b>B1</b>, 50 µm; <b>B2</b>, 20 µm; <b>B3</b>, 33.3 µm), and (<b>C</b>) height measurements at the cross section of an individual cell. …”

Antineoplastic Effects of siRNA against TMPRSS2-ERG Junction Oncogene in Prostate Cancer by Giorgia Urbinati (554921)

“…The siRNA against TMPRSS2-ERG fusion variant IV showed the highest anti-proliferative effects: Significantly decreased cell viability, increased cleaved caspase-3 and inhibited a cluster of anti-apoptotic proteins. …”

Baseline characteristics of women by randomization method^$ (mITT analysis). by Chanel Avenant (409756)

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

Subjects:

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

Subjects:

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

Subjects:

6:2 Chlorinated Polyfluoroalkyl Ether Sulfonate (F-53B) Induces Aging and Parkinson’s Disease-like Disorders in <i>C. elegans</i> at Low Concentrations by Hui Li (32376)

Subjects:

A Functional 12T-Insertion Polymorphism in the <i>ATP1A1</i> Promoter Confers Decreased Susceptibility to Hypertension in a Male Sardinian Population by Victoria L. Herrera (383897)

“…The <i>ATP1A1</i> promoter containing the 12T-insertion exhibited decreased transcriptional activity in in vitro reporter-assay systems, indicating decreased α1Na,K-ATPase expression with the 12T-insertion, compared with the 12T-deletion <i>ATP1A1</i> promoter. …”